Lindsay Rosenwald

Lindsay A. Rosenwald is a prominent figure in the biotechnology and life sciences sectors, recognized for his extensive experience as a physician and investor. He received his M.D. from Temple University School of Medicine and holds a B.S. in Finance from Pennsylvania State University.135

Career Overview

• Entrepreneurship: Rosenwald is the co-founder of Fortress Biotech, where he serves as Chairman, President, and CEO. He has been instrumental in founding and recapitalizing numerous public and private biotechnology companies over the past 25 years.23
• Investment: He co-founded Opus Point Partners, a healthcare private equity firm, focusing on investments in life sciences.13 His ventures have led to the development of several FDA-approved medications for conditions like acute promyelocytic leukemia and prostate cancer.1
• Board Memberships: Rosenwald holds positions on the boards of various biotech firms, including Mustang Bio, Checkpoint Therapeutics, and Avenue Therapeutics.45

Contributions to Medicine

Rosenwald's work has significantly impacted the treatment landscape for various diseases, with his companies developing therapies that have cured thousands of patients.1 He also founded the Rosenwald Foundation, which supports scientific and medical education initiatives.1

Education

• M.D.: Temple University School of Medicine
• B.S.: Finance, Pennsylvania State University

Rosenwald's blend of medical expertise and financial acumen has positioned him as a key player in advancing biotechnology innovations and investments.